Diabetes-like alterations in hemostatic parameters after growth hormone administration for one week in normal man

Lundbæk, 1970, Diabetes, diabetic angiopathy and growth hormone, Lancet, II, 131, 10.1016/S0140-6736(70)92706-6 Hansen, 1970, Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normal and juvenile diabetes, Diabetologia, 6, 27, 10.1007/BF00425888 Sperling, 1973, Daily production and metabolic clearance of growth hormone in diabetes mellitus, Diabetologia, 9, 380, 10.1007/BF01239431 Vigneri, 1976, Growth hormone levels in diabetes: correlation with the clinical control of the disease, Diabetes, 25, 167, 10.2337/diabetes.25.3.167 Merimee, 1978, A follow-up study of vascular disease in growth hormone-deficient dwarfs with diabetes, N Engl J Med, 289, 1217, 10.1056/NEJM197806012982202 Passa, 1974, Influence of muscular exercise on plasma levels of growth hormone with and without retinopathy, Lancet, II, 72, 10.1016/S0140-6736(74)91635-3 Kohner, 1976, Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation, Diabetes, 25, 104, 10.2337/diabetes.25.2.104 Hansen, 1972, Growth hormone secretion and kidney function during normalization of the metabolic state in untreated juvenile diabetics, Horm Metab Res, 4, 11, 10.1055/s-0028-1094108 Christiansen, 1982, Kidney function and size in Type 1 diabetes patients before and during growth hormone administration for one week, Diabetologia, 22, 333, 10.1007/BF00253577 Seyer-Hansen, 1981, Renal hypertrophy in diabetes and after unilateral nephrectomy: similarities and differences, Acta Endocrinol [Suppl] (Copenh), 242, 45 Mogensen, 1984, Predicting diabetic nephropathy in insulin-dependent patients, N Engl J Med, 311, 89, 10.1056/NEJM198407123110204 Brenner, 1981, The role of giomerular hyperfiltration in the initiation and progression of diabetic nephropathy, Acta Endocrinol [Suppl] (Copenh), 242, 7 Ledet, 1976, Growth hormone simulating the growth of arterial medial cells in vitro: absence of the effect of insulin, Diabetes, 25, 1011, 10.2337/diabetes.25.11.1011 Ledet, 1985, Growth hormone effect on accumulation of arterial basement membrane-like material, studies on rabbit aortic myomedial cell cultures, Diabetologia, 28, 922, 10.1007/BF00703138 Beaser, 1944, Capillary fragility in relation to diabetes mellitus, hypertension and age, Arch Intern Med, 73, 18, 10.1001/archinte.1944.00210130026004 Christensen, 1968, Increased skin capillary resistance after hypophysectomy in long term diabetes, Lancet, II, 1270, 10.1016/S0140-6736(68)91762-5 Christensen, 1971, Quantitative measurements of skin capillary resistance in hypophysectomized long-term diabetics, Diabetes, 20, 297, 10.2337/diab.20.5.297 Sarji, 1977, Relation between growth hormone levels and von Willebrand factor activity, J Clin Endocrinol Metab, 45, 853, 10.1210/jcem-45-4-853 Greaves, 1987, Changes in the factor VIII complex in diabetic ketoacidosis—evidence of endothelial damage, Diabetologia, 30, 160, 10.1007/BF00274221 Borkenstein, 1984, Effects of growth hormone on the factor VIII complex in patients with growth hormone deficiency, Metabolism, 33, 1065, 10.1016/0026-0495(84)90088-X Lowe, 1982, Effects of growth hormone glucose and insulin on the factor VIII complex, Thromb Res, 28, 201, 10.1016/0049-3848(82)90262-6 Sundquist, 1984, Growth hormone and endothelial function during exercise in diabetics with and without retinopathy, Acta Med Scand, 215, 55, 10.1111/j.0954-6820.1984.tb04969.x Ingerslev, 1986, Enzyme linked immuno sorbent assay (ELISA) for factor VIII coagulant antigen (CAg) using haemophilic antibodies, Br J Haematol, 62, 325, 10.1111/j.1365-2141.1986.tb02936.x Ingerslev, 1987, A sensitive ELISA for von Willebrand factor (vWf:Ag), Scand J Clin Lab Invest, 47, 143, 10.3109/00365518709168882 Nakane, 1974, Peroxidase-labelled antibody: a new method of conjugation, J Histochem Cytochem, 22, 1084, 10.1177/22.12.1084 Ørskov, 1968, Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone, Nature, 219, 193, 10.1038/219193b0 Pandolfi, 1974, Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy, Acta Ophthalmol, 52, 823, 10.1111/j.1755-3768.1974.tb01119.x Gensini, 1979, Changes of platelet function and blood clotting in diabetes mellitus, Thromb Haemost, 42, 983, 10.1055/s-0038-1656989 Dornan, 1983, Plasma haemostatic factors and diabetic retinopathy, Eur J Clin Invest, 13, 231, 10.1111/j.1365-2362.1983.tb00093.x Christie, 1984, Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and patients with vasculopathy, Thromb Haemost, 52, 138, 10.1055/s-0038-1661158 Borsey, 1984, Platelet and coagulation factors in proliferative diabetic retinopathy, J Clin Pathol, 37, 659, 10.1136/jcp.37.6.659 Solerte, 1985, Plasma fibronectin, von Willebrand factor antigen, and blood rheology: association with diabetic microvascular disease, Acta Diabetol Lat, 22, 239, 10.1007/BF02590775 Jaffe, 1974, Synthesis of von Willebrand factor by cultured human endothelial cells, 71, 1906 Ingerslev, 1989, Synthesis of factor VIII by human hepatocytes in culture, Thromb Haemost, 60, 387 Stel, 1983, Detection of factor VIII/coagulant antigen in human liver tissue, Nature, 303, 530, 10.1038/303530a0 Kadhom, 1988, Factor VIII procoagulant antigen in human tissues, Thromb Haemost, 59, 289, 10.1055/s-0038-1642773 Mannucci, 1977, 1-desamino-8-D arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease, Lancet, I, 869, 10.1016/S0140-6736(77)91197-7 Jaffe, 1978, Synthesis of fibronectin by cultured human endothelial cells, J Exp Med, 147, 1779, 10.1084/jem.147.6.1779 Sloth Christiansen, 1988, Human hepatocytes in culture synthesize and secrete fibronectin, Scand J Clin Lab Invest, 48, 685, 10.3109/00365518809085791 Geiger, 1984, Plasminogen activation in diabetes mellitus: kinetic analysis of plasmin formation using components isolated from plasma of diabetic donors, J Biol Chem, 259, 3976, 10.1016/S0021-9258(17)43245-5 Geiger, 1985, Plasminogen activation in diabetes mellitus: normalization of blood sugar levels improves impaired enzyme kinetics in vitro, Thromb Haemost, 54, 413, 10.1055/s-0038-1657861